PERSPECTA

News from every angle

← Back to headlines

Genentech's Tecentriq Approved for Bladder Cancer Indication

Genentech has received approval for a new bladder cancer indication for its drug, Tecentriq, expanding its therapeutic use.

15 May, 18:00 — 15 May, 18:00
PostShare

Sources

Showing 1 of 1 sources
seeking-alphaMixed105d ago

Genentech gains bladder cancer indication for Tecentriq

Read full article →

Related Stories

BioNTech Ends Mid-Stage Colorectal Cancer Vaccine Trial

1h ago

Dolly Parton’s Sister Reveals Singer’s Final Cancer Battle and Generosity

2h ago

Second Victim Dies Following Catastrophic Fire in Omišu, Croatia

2h ago

UK Prime Minister Burnham to Abstain on Assisted Dying Bill

2h ago